Opnurasib
Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.
Product Specifications
CAS Number
2653994-08-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
526.03
Molecular Formula
C29H28ClN7O
Notes
Research use only, not for human use.
Receptor
Kras
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPC28917-01 Inquire
Recombinant Human Fibroblast growth factor 2 (FGF2), Active Protein
Sign In for Pricing
View Details RPC28917-02 1 mg
Recombinant Human Fibroblast growth factor 2 (FGF2), Active Protein
Sign In for Pricing
View Details 
133535-ML405 100 µL
SMAD1 (Mothers Against Decapentaplegic Homolog 1, Mothers Against DPP Homolog 1, MAD Homolog 1, MADH1, SMAD Family Member 1, SMAD 1, hSMAD1, BSP-1, BSP1, JV4-1, JV41, Mad-related Protein 1, MADR1, Transforming Growth Factor-beta-signaling Protein 1) (MaxLight 405) discontinued
Sign In for Pricing
View Details